<dd id='NZUNF'><tbody id='arWVO'><td id='X5hUr'><optgroup id='iHmds'><strong id='7PXUl'></strong></optgroup><address id='PesNU'><ul id='WhOKj'></ul></address><big id='Dop6a'></big></td><table id='ILFMK'></table></tbody><pre id='3WSlV'></pre></dd><span id='o9LkD'><b id='9baCZ'></b></span>
<dfn id='vjBlA'><optgroup id='AKBa8'></optgroup></dfn><tfoot id='Cwnw1'><bdo id='JT78Z'><div id='I9c0s'></div><i id='Lmybb'><dt id='DwZcg'></dt></i></bdo></tfoot>
<ul id='wseju'></ul>
<fieldset id='3AJZC'></fieldset>
亞盛醫藥任命(ming)Veet Misra博(bo)士(shi)(shi)為(wei)首席財(cai)務(wu)官(guan)，并任命(ming)黃智先(xian)生為(wei)全球企業發展&財(cai)務(wu)高級副總裁。Misra博(bo)士(shi)(shi)和黃智先(xian)生均向公(gong)司董事長、CEO楊大俊博(bo)士(shi)(shi)直接匯報。（美(mei)通社）
<option id='PdQR7'></option><select id='m3Qbm'><span id='Qoy8P'><form id='ILUgB'></form></span><dd id='vqz0F'></dd></select><dt id='A8nEa'></dt><style id='pPlbD'><big id='hXft5'><i id='GyHsd'></i><tbody id='4NBlC'></tbody></big></style><abbr id='IXbpG'></abbr>
